New enhanced recovery pathway after hipec improves outcomes
A treatment option that has shown to improve clinical outcomes and prognosis in patients with peritoneal metastasis is cytoreductive surgery with hyperthermic intraperitoneal chemotherapy(HIPEC).While HIPEC can improve disease-free survival in many patients,it’s a major operation
2022-10-18
Compared with other high-risk procedures in cancer,cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy(HIPEC)for patients with peritoneal metastasis was associated with lower 30-day mortality rates and either similar or lower infection rates,a retrospective database study found
2022-10-18
Study Results Show Low Morbidity, Mortality Rates for Patients Treated with HIPEC
BUFFALO,NY—Researchers at Roswell Park Comprehensive Cancer Center(Roswell Park)have determined that cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy(CS/HIPEC),a complex procedure to treat advanced abdominal cancers,can be done safely,and may be an effective therapy for select patients.Study results
2022-10-18
Quality of Life Still Good with HIPEC Surgery for Peritoneal Mesothelioma
Surgical oncologist Dr.Edward Levinewas not surprised by the encouraging results of the recent study measuring quality-of-life issues following aggressive treatment for patients with peritoneal mesothelioma
2022-10-18
How much do you know about GD body cavity thermal perfusion therapy machine?
Xi'an Gooddoctor Medical Technology Co., Ltd. (GD) is a professional medical technology company that takes the lead in adopting continuous constant temperature circulation hot perfusion therapy technology at home and abroad.
2022-09-23